Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Asian elephant survives Ebola-like virus
Tarli with Woburn’s head elephant keeper Darren Fellowes.

Vets treat three-year-old Tarli for Endotheliotropic herpes virus

An Asian elephant has beaten the odds to survive an Ebola-like virus which is fatal in 80 per cent of recorded cases.

Elephant endotheliotropic herpesvirus (EEHV) is a highly fatal disease that weakens the circulatory system in young elephants leading to rapid deterioration.

In November 2017, keepers at Woburn Safari Park carried out a routine blood test on three-year-old Tarli, which revealed that she had EEHV infection. Although she did not have any clinical signs, vets began treatment immediately to give her the best chance of survival.

Treatment for EEHV is mostly supportive, focussing on maintaining bodily function while the immune system fights the disease. A two-week course of antiviral and transfusions was combined with 24-hour supervision from keepers who had cared for Tarli since she was born.

“EEHV is an awful virus, targeting the youngest members of the herd. As keepers we spend more time with our animals than our families and all of us are so relieved at how positively Tarli has responded to treatment,” said Darren Fellowes, Woburn’s head elephant keeper.

The keepers focussed on keeping Tarli calm so that she could remain with the rest of the herd and keep to her usual routine. In a press release, Woburn Safari Park said that the use of intravenous ganciclovir and plasma has had a successful outcome and ‘opens the door to offering alternative treatment protocols’.

It has now been six weeks since Tarli received the all-clear. However, there is still a chance of relapse. The team are cautiously celebrating her recovery whilst they continue to monitor her closely.

Woburn Safari Park raises money for International Elephant Foundation which invests in elephant conservation and research, including for an EEHV vaccine.

“EEHV is the most serious medical threat to the survival of Asian elephant calves. Every case builds on the experience of others, and the body of research around earlier cases allowed us to create an effective treatment programme for Tarli, and ultimately saved her life,” explained specialist vet Nathalie Wissink-Argilaga who led Tarli’s treatment.

“Details of Tarli’s recovery are being shared with the international veterinary community and we hope to share lessons on the value of swift treatment, stress-reduction, continuous monitoring of viral loads and blood parameters and intravenous administration of antivirals and plasma.” 

Image (C) Woburn Safari Park

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
New form for online veterinary medicines retailers

The Veterinary Medicines Directorate (VMD) has produced a new online form for retailers wishing to sell veterinary medicines on the internet.

The form replace the previous Word version and is part of the VMD's ongoing commitment to digitise its processes. Anyone retailing prescription medicines online, including POM-V, POM-VPS and NFA-VPS categories, is lawfully required to register with the VMD before trading.

The change only applies to new applicants. Retailers already listed on the VMD's Register of Online Retailers or registered under the Accredited Internet Retailer Scheme (AIRS) do not need to do anything.